Coffee, longevity and caffeine metabolism
A large UK study raises interesting questions without settling cause and effect.
What did the study ask?
Researchers studied roughly half a million UK Biobank participants to explore the relationship between coffee drinking and mortality. They also examined whether a genetic score related to caffeine metabolism changed that relationship.
What the researchers observed
Over about a decade of follow-up, coffee consumption was associated with lower all-cause mortality. Similar patterns appeared for ground, instant and decaffeinated coffee. The association did not meaningfully differ across the caffeine-metabolism genetic scores examined.
Why decaf is part of the story
The decaffeinated-coffee result makes it difficult to credit caffeine alone. Other coffee compounds, associated habits or remaining confounding could contribute. The study was observational, so it cannot establish that adding coffee, or caffeine, to someone’s routine extends that person’s life.
What about high intake and genetics?
An association at high reported coffee intake is not a safety recommendation. Nor does a population-level genetic analysis tell an individual that a large caffeine amount is appropriate. Self-reported intake and the limitations of an observational cohort remain relevant even when the sample is very large.
The buyer’s takeaway
This is a coffee-and-health study, not a clinical trial of caffeine pills or a dosing guide. A large participant count makes the question worth examining, but it does not remove the difference between correlation and cause. Keep longevity claims separate from evidence about temporary alertness.
